Home/News/Press Releases/TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Press ReleasesTIF NewsNews TIF Supports Administration Of COVID-19 Vaccine Booster Dose To Patients With Haemoglobin Disorders Less than a minute 211020_ TIF Announcement_COVID-19 Vaccine Boosters TagsVaccinations Patients Haemoglobin Disorders Healthcare Professionals Thalassaemia COVID-19 Vaccines AtRisk Vulnerable Sickle cell #news TIF News COVID-19 Pandemic COVID-19 Less than a minute Facebook X LinkedIn Share via Email Print
